dHMN1-UBE3C

UBE3C | 2023

What Is dHMN1-UBE3C?

dHMN1-UBE3C is a type of CMT caused by autosomal dominant mutations in the UBE3C gene. This gene provides instructions for making a protein that tags other proteins for regulated breakdown within nerve cells. Mutations in the UBE3C gene disrupt this function, leading to impaired nerve signal transmission.

dHMN1-UBE3C is autosomal dominant, meaning that just one of the gene’s two copies needs a mutation to cause this subtype.

Clinical Features

The age of symptom onset in dHMN1-UBE3C is variable, ranging from childhood to adulthood. As a motor neuropathy, dHMN1-UBE3C primarily affects the most distal points, with weakness and atrophy of the feet and hands, and little to no involvement of the sensory nerves. Nerve conduction studies usually show somewhat slowed conduction velocities and reduced amplitudes, consistent with an axonal form of CMT.

dHMN1-UBE3C symptoms may include:

  • Weakness and atrophy in the feet and lower legs
  • Foot drop
  • Reduced or absent reflexes
  • A steppage-style walking pattern
  • Foot deformities, including high arches, and hammertoes (clawed toes)
  • Progressive involvement of the hands
  • Difficulty with fine motor skills and manual dexterity
  • Additional symptoms not listed here

Disease Course

dHMN1-UBE3C shows wide variability in severity and progression. Some individuals are mildly affected, while others develop a more severe disease. Disease progression is generally slow, and life expectancy is not reduced.

Clinical Basics

Subtype
dHMN1-UBE3C

Classification
dHMN/HMN

Neuropathy Type
Axonal

Inheritance Pattern
autosomal dominant

Genetic Context

HGNC-Approved Gene Symbol
UBE3C

Gene Full Name
Ubiquitin Protein Ligase E3c

HGNC Gene Alias(es)
KIAA0010

Chromosome
7q36.3

Zygosity of Responsible Variant
Heterozygous

Variant Mechanism

Loss of Function (LoF)

Details

Mechanistic basis:
Haploinsufficiency

Confidence:
Medium

Prediction:
The literature predicts a loss-of-function mechanism for dHMN1-UBE3C: the single reported autosomal dominant case is a UBE3C-intergenic gene fusion (UBE3C-IF) whose transcript lowers levels of full-length wild-type UBE3C, the ubiquitin ligase, in patient iPSC-derived motor neurons. Because the fusion reduces the dosage of wild-type enzyme rather than interfering with the residual protein, restored wild-type UBE3C is predicted to rescue, consistent with haploinsufficiency. Evidence is limited to a single 2023 report, holding confidence at medium.

Rationale:
The UBE3C-intergenic fusion lowers levels of full-length wild-type UBE3C in patient iPSC-derived motor neurons, reducing enzyme dosage rather than interfering with the residual protein. Because restoring wild-type UBE3C is predicted to rescue, the mechanism is haploinsufficiency-type loss of function. The single-report basis holds confidence at medium.

ClinVar Pathogenic Variants

View dHMN1-UBE3C ClinVar Variants

UBE3C OMIM Entry

UBE3C OMIM

More Info

dHMN1-UBE3C Research Opportunity

CMT Natural History Study

Original Discovery Publication

Publication Title

Novel Gene-Intergenic Fusion Involving Ubiquitin E3 Ligase UBE3C Causes Distal Hereditary Motor Neuropathy

Authors

Cutrupi, A.N., Narayanan, R.K., Perez-Siles, G., Grosz, B.R., Lai, K., Boyling, A., Ellis, M., Lin, R.C.Y., Neumann, B., Mao, D., Uesugi, M., Nicholson, G.A., Vucic, S., Saporta, M.A., & Kennerson, M.L.

Publication Date
March 1, 2023

Updated: July 18, 2026 | By: K. Raymond

The Dorsal Root

More From The Dorsal Root


Jean-Martin Charcot lecturing at the Salpêtrière while comparing anatomical illustrations of a cavovarus Charcot-Marie-Tooth (CMT) foot and a Charcot neuroarthropathy foot, highlighting two different conditions that share the Charcot name.


A Name That Does Too Much Work

Jean-Martin Charcot's name appears throughout medicine, but nowhere does it create more confusion than in the foot. Learn why the CMT foot and Charcot neuroarthropathy, also known as Charcot foot, share a name yet differ in how they develop, appear, and are managed.


Close-up of a doctor’s hand holding a prescription pad while a patient’s wrist is wrapped with metal chains.


When Medicine Lost Its Compass

Evidence failed not because it was wrong, but because it was weaponized. I lived the downstream effects of that failure for more than a decade. This is what happens when medicine forgets that data always ends in a human being.


Illustrated graphic showing large ‘404’ numerals with people interacting with data screens and servers, alongside text reading ‘CMT Genetic Testing Error 404: Gene Not Found’ and ‘Examining Why Less Than Half of All Who Have Charcot-Marie-Tooth Disease Are Not Able to Obtain Genetic Confirmation of Their Disease.


Error 404: Gene Not Found

CMT genetic testing often fails to identify the cause of the disease, even when comprehensive panels are used. Here, we discuss why this happens, what genetic tests can and cannot do, and why a negative result still matters.